Quantcast

Latest LRRK2 Stories

2014-08-05 12:32:03

NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease. But do the participants have to know? A group of 35 Parkinson's disease (PD) researchers published today in Genetics of Medicine the different answers to that question among sites investigating mutations in the LRRK2 gene, the greatest known genetic contributor to PD. Investigators from The Michael...

2014-03-26 12:28:27

Biomedical research institute appoints two key positions, expanding its impact on neurodegenerative science GRAND RAPIDS, Mich., March 26, 2014 /PRNewswire/ -- Van Andel Research Institute's Center for Neurodegenerative Science continues to expand its research portfolio and increase its impact in the field of Parkinson's disease research. The Center recently appointed Dr. Jiyan Ma, whose laboratory studies prions, the misfolded proteins associated with many contagious...

2014-02-25 08:33:01

NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson's Research (MJFF), is expanding to study individuals with genetic mutations associated with Parkinson's disease (PD). Researchers hope that greater understanding of the biology and clinical features of these participants -- people with or at risk to develop Parkinson's -- will lead to...

2014-01-08 17:05:18

Gladstone findings challenge conventional wisdom; point to new therapeutic strategies The most devastating aspect of Parkinson's disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement. It may not be the millions around the world and their families who suffer each day from the disease's harmful effects. Instead, it may in fact be that its root causes remain largely a mystery. But now, scientists at the Gladstone Institutes have...

2013-03-18 10:56:41

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology (AAN), March 16-23, 2013, in San Diego. For additional information, or to arrange an interview, please contact Karin Eskenazi at 212-342-0508 or ket2116@columbia.edu, or Christina Stolfo at 212-305-5587 or chs9135@nyp.org ORAL PRESENTATIONS Deoxypyrimidine Monophosphates Treatment for Thymidine Kinase 2...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related